A new market research report on
the Global In Vitro Fertilization (IVF) Services market has introduced
by KD Market Insights. The report is dedicated to in-depth industry
analysis of the global In Vitro Fertilization (IVF) Services market. The
Global In Vitro
Fertilization (IVF) Services analysis is broken down on different segmentation levels including Market Market by End Users, Market,
By Geography.
The global IVF market generated
a revenue of $9,876 million in 2016 and is expected to reach $19.676 million by
2023, at a CAGR of 10.5% during the analysis
period, 2017-2023. The growth of the market is attributed to the reduced
conceiving rates, delayed pregnancy, changing lifestyle conditions and
fertility disorders are the major factors that drive the market growth. Other
factors such as favorable reimbursement scenario and delayed parenthood opted
by couples due to professional and financial constraints will also help in the
growth of the market. On the other hand, barriers such as ethical concerns in
particular countries with respect to IVF, high cost of the IVF procedures
followed by low awareness, especially in under-developed economies such as
Nigeria are likely to restrain the market growth.
Rising initiatives towards commercialization of cost-efficient
treatments and emerging medical tourism, mainly in developing nations would
offer lucrative growth opportunities for IVF service providers in future.
Further, the growing clinical research initiatives for the development of novel
IVF technologies would provide a platform for growth of the global IVF market.
The
world IVF market is segmented on the basis of cycle type, end users and
geography. Based on cycle types, the market is segmented into fresh cycle
(non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh cycle
(non-donor) is both the highest revenue generating segment as well as the
highest growing segment as it is the most commonly adopted method in a IVF
process due to high success rate. Similarly, by end users, the market is
further segmented into fertility clinics, hospitals, surgical centers and
clinical research institutes. In terms of geography, the market is segmented
into North America, Europe, Asia-Pacific (APAC) and Latin America, Middle East
and Africa (LAMEA).
KEY BENEFITS FOR STAKEHOLDERS:
-
The report provides an in-depth analysis of the IVF market across major
countries with a cross sectional analysis of the number of IVF cycles
performed, and total revenue generated during the forecast period.
- The report helps in understanding the strategies adopted by various IVF clinics and hospitals, in order to gain a higher market share in the global IVF market.
- Region-wise and country-wise share in the global IVF market is comprehensively analyzed in the report.
- The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2017-2023, in terms of value and volume.
- The study provides an in-depth analysis of the world IVF Services market with current trends and future estimations to elucidate the imminent investment pockets.
- The report helps in understanding the strategies adopted by various IVF clinics and hospitals, in order to gain a higher market share in the global IVF market.
- Region-wise and country-wise share in the global IVF market is comprehensively analyzed in the report.
- The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2017-2023, in terms of value and volume.
- The study provides an in-depth analysis of the world IVF Services market with current trends and future estimations to elucidate the imminent investment pockets.
KEY MARKET SEGMENTS:
Market by End Users
-
Fertility Clinics
- Hospitals
- Surgical centers
- Clinical research institutes
- Hospitals
- Surgical centers
- Clinical research institutes
Market, By Geography
North
America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Denmark
- Russia
- Others Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- New Zealand
- Korea
- Thailand
- Others APAC
LAMEA
- Latin America
- Middle East
- Africa
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Denmark
- Russia
- Others Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- New Zealand
- Korea
- Thailand
- Others APAC
LAMEA
- Latin America
- Middle East
- Africa
Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/in-vitro-fertilization-ivf-services-market-amr
Table of Content
CHAPTER 1 INTRODUCTION
1.1.
REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1.
Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 WORLD IN VITRO
FERTILIZATION (IVF) MARKET OVERVIEW
3.1.
MARKET DEFINITION AND SCOPE
3.2. IVF PRICING TRENDS BY COUNTRY
3.3. IVF CYCLES BY COUNTRY
3.4. GLOBAL IVF MARKET BY END USERS
3.2. IVF PRICING TRENDS BY COUNTRY
3.3. IVF CYCLES BY COUNTRY
3.4. GLOBAL IVF MARKET BY END USERS
3.4.1.
Fertility clinics
3.4.2. Hospitals
3.4.3. Surgical centers
3.4.4. Clinical research institutes
3.4.2. Hospitals
3.4.3. Surgical centers
3.4.4. Clinical research institutes
3.5.
GLOBAL IVF MARKET BY CYCLE TYPE
3.5.1.
Fresh IVF cycles (non-donor)
3.5.2. Thawed IVF cycles (non-donor)
3.5.3. Donor egg IVF cycles
3.5.2. Thawed IVF cycles (non-donor)
3.5.3. Donor egg IVF cycles
3.6.
MARKET DYNAMICS
3.6.1.
Drivers
3.6.1.1.
Delayed pregnancies
3.6.1.2. Rise in global infertility rates
3.6.1.3. Emergence of new fertility tourism destinations
3.6.1.2. Rise in global infertility rates
3.6.1.3. Emergence of new fertility tourism destinations
3.6.2.
Restraints
3.6.2.1.
High Cost involved in the treatment
3.6.2.2. Low level of awareness in developing economies
3.6.2.3. Inadequate reimbursements policies for IVF treatments
3.6.2.4. Ethical Considerations
3.6.2.2. Low level of awareness in developing economies
3.6.2.3. Inadequate reimbursements policies for IVF treatments
3.6.2.4. Ethical Considerations
3.6.3.
Opportunities
3.6.3.1.
relaxing the legal considerations on ivf treatments
3.6.3.2. New technology development and treatment options
3.6.3.3. Three parent IVF
3.6.3.2. New technology development and treatment options
3.6.3.3. Three parent IVF
3.7.
KEY FINDINGS
CHAPTER 4 NORTH AMERICA IVF MARKET
4.1.
UNITED STATES IVF MARKET, (REVENUE AND NUMBER OF CYCLES)
4.1.1.
Number of Infertility Clinics, 2016
4.1.2. United States IVF Market by End Users
4.1.2. United States IVF Market by End Users
4.1.2.1.
Fertility clinics
4.1.2.2. Hospitals
4.1.2.3. Surgical centers
4.1.2.4. Clinical research institutes
4.1.2.2. Hospitals
4.1.2.3. Surgical centers
4.1.2.4. Clinical research institutes
4.1.3.
United States IVF market by cycle type
4.1.3.1.
Fresh IVF cycles (non-donor)
4.1.3.2. Thawed IVF cycles (non-donor)
4.1.3.3. Donor egg IVF cycles
4.1.3.2. Thawed IVF cycles (non-donor)
4.1.3.3. Donor egg IVF cycles
4.1.4.
Drivers
4.1.4.1.
Increasing popularity of IVF in United States
4.1.4.2. Increased rate of infertility and practices of embryo banking cycles
4.1.4.2. Increased rate of infertility and practices of embryo banking cycles
4.1.5.
Restraints
4.1.5.1.
High cost of IVF treatment in United Sates
4.1.5.2. Restrictions on 3-parent IVF treatments
4.1.5.3. Scattered Reimbursements
4.1.5.2. Restrictions on 3-parent IVF treatments
4.1.5.3. Scattered Reimbursements
4.1.6.
Regulatory Issues, Legislations and Authorities
4.1.7. Insurance Reimbursement Scenario
4.1.8. Company Profile
4.1.7. Insurance Reimbursement Scenario
4.1.8. Company Profile
4.1.8.1.
Fertility and Gynecology Center Monterey Bay IVF
4.1.8.2. Conceptions Reproductive Associates
4.1.8.3. Servy Massey Fertility Institute
4.1.8.4. Sher Institute for Reproductive Medicine (SIRM)
4.1.8.5. Cardone Reproductive Medicine & Infertility
4.1.8.6. Fertility Center of San Antonio
4.1.8.7. Houston Fertility Center
4.1.8.8. New hope fertility center
4.1.8.9. Reproductive Medicine Associates Of New Jersey
4.1.8.2. Conceptions Reproductive Associates
4.1.8.3. Servy Massey Fertility Institute
4.1.8.4. Sher Institute for Reproductive Medicine (SIRM)
4.1.8.5. Cardone Reproductive Medicine & Infertility
4.1.8.6. Fertility Center of San Antonio
4.1.8.7. Houston Fertility Center
4.1.8.8. New hope fertility center
4.1.8.9. Reproductive Medicine Associates Of New Jersey
4.2.
CANADA IVF MARKET (REVENUE AND NUMBER OF CYCLES)
4.2.1.
Number of infertility centers
4.2.2. Canada IVF Market by End users
4.2.2. Canada IVF Market by End users
4.2.2.1.
Fertility clinics
4.2.2.2. Hospitals
4.2.2.3. Surgical centers
4.2.2.4. Clinical research institutes
4.2.2.2. Hospitals
4.2.2.3. Surgical centers
4.2.2.4. Clinical research institutes
4.2.3.
Canada IVF market by cycle type
4.2.3.1.
Fresh IVF cycles (non-donor)
4.2.3.2. Thawed IVF cycles (non-donor)
4.2.3.3. Donor egg IVF cycles
4.2.3.2. Thawed IVF cycles (non-donor)
4.2.3.3. Donor egg IVF cycles
4.2.4.
Market Dynamics
4.2.4.1.
Drivers
4.2.4.1.1.
Commercialization of IVF booster in Canada
4.2.4.2.
Restraints
4.2.4.2.1.
High cost of IVF in Canada
4.2.5.
Regulatory Issues, Legislations and Authorities
4.2.6. Insurance Reimbursement Scenario
4.2.7. Company Profile
4.2.6. Insurance Reimbursement Scenario
4.2.7. Company Profile
4.2.7.1.
Toronto Centre for Advanced Reproductive Technology Ltd.
4.2.7.2. Fertility Treatment Center
4.2.7.3. Montreal Fertility Center
4.2.7.2. Fertility Treatment Center
4.2.7.3. Montreal Fertility Center
4.3.
MEXICO IVF MARKET (REVENUE AND NUMBER OF CYCLES)
4.3.1.
Number of infertility centers
4.3.2. Mexico IVF Market by End Users
4.3.2. Mexico IVF Market by End Users
4.3.2.1.
Fertility clinics
4.3.2.2. Hospitals
4.3.2.3. Surgical centers
4.3.2.4. Clinical research institutes
4.3.2.2. Hospitals
4.3.2.3. Surgical centers
4.3.2.4. Clinical research institutes
4.3.3.
Mexico IVF market by cycle type
4.3.3.1.
Fresh IVF cycles (non-donor)
4.3.3.2. Thawed IVF cycles (non-donor)
4.3.3.3. Donor egg IVF cycles
4.3.3.2. Thawed IVF cycles (non-donor)
4.3.3.3. Donor egg IVF cycles
4.3.4.
Market Dynamics
4.3.4.1.
Drivers
4.3.4.1.1.
Fertility tourism
4.3.4.1.2. Comparatively low cost of IVF
4.3.4.1.2. Comparatively low cost of IVF
4.3.4.2.
Restraints
4.3.4.2.1.
Language Barriers
4.3.5.
Regulatory Issues, Legislations and Authorities
4.3.6. Insurance Reimbursement Scenario
4.3.7. Company Profile
4.3.6. Insurance Reimbursement Scenario
4.3.7. Company Profile
4.3.7.1.
Liv Fertility Center In Puerto Vallarta
4.3.7.2. BFC Biofertility Center
4.3.7.2. BFC Biofertility Center
CHAPTER 5 EUROPE IVF MARKET
(REVENUE AND NUMBER OF CYCLES)
5.1.
GERMANY IVF MARKET (REVENUE AND NUMBER OF CYCLES)
5.1.1.
Number of infertility clinics in Germany
5.1.2. Germany IVF Market by End Users
5.1.2. Germany IVF Market by End Users
5.1.2.1.
Fertility clinics
5.1.2.2. Hospitals
5.1.2.3. Surgical centers
5.1.2.4. Clinical research institutes
5.1.2.2. Hospitals
5.1.2.3. Surgical centers
5.1.2.4. Clinical research institutes
5.1.3.
Germany IVF market by cycle type
5.1.3.1.
Fresh IVF cycles (non-donor)
5.1.3.2. Thawed IVF cycles (non-donor)
5.1.3.2. Thawed IVF cycles (non-donor)
5.1.4.
Market Dynamics
5.1.4.1.
Drivers
5.1.4.1.1.
Subsidizing IVF treatments
5.1.4.1.2. Delayed Marriages and Parenthood decisions
5.1.4.1.2. Delayed Marriages and Parenthood decisions
Continue @...
About Us:
KD Market
Insights offers a
comprehensive database of syndicated research studies, customized reports, and
consulting services. These reports are created to help in making smart, instant
and crucial decisions based on extensive and in-depth quantitative information,
supported by extensive analysis and industry insights. Our dedicated in-house
team ensures the reports satisfy the requirement of the client. We aim at
providing value service to our clients. Our reports are backed by extensive
industry coverage and is made sure to give importance to the specific needs of
our clients. The main idea is to enable our clients to make an informed
decision, by keeping them and ourselves up to date with the latest trends in
the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
No comments:
Post a Comment